Literature DB >> 22204866

The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2.

Herve Y Sroussi1, Yu Lu, Dana Villines, Ying Sun.   

Abstract

S100A8 and S100A9 regulate polymorphonuclear neutrophils (PMNs) recruitment and represent 40% of PMN cytosolic protein weight. We have shown that S100A8/S100A9 inhibit PMN oxidative metabolism. The present study was designed to elucidate the mechanisms of this anti-oxidative effect. We hypothesized that the protease activated receptor-2 (PAR-2) played a role in the down-regulation of PMN oxidative metabolism by S100A8/S100A9. Freshly isolated PMNs were tested for their ability to oxidize dichlorofluorescin-diacetate. Functional inhibition of PAR-2 with ENMD-1068, the pepducin P2pal-21 or an antibody directed at PAR-2 cleavage/activation site, resulted in a significant inhibition of S100A8 and S100A9 anti-oxidative effect. Conversely, the controlled activation of PAR-2 potentiated S100 anti-oxidative effect. Taken together, the data indicate that the anti-oxidative effect of S100A8/A9 is initiated by PAR-2 activation. S100A8/S100A9 may therefore dampen inflammation without interfering with its initial strength. This finding opens translational possibilities to limit deleterious PMN activation with a dual PAR-2/S100 strategy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22204866      PMCID: PMC3288784          DOI: 10.1016/j.molimm.2011.12.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  50 in total

1.  Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides.

Authors:  Lidija Covic; Amy L Gresser; Joyce Talavera; Steven Swift; Athan Kuliopulos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 2.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism.

Authors:  Barry Sampson; Magne K Fagerhol; Cord Sunderkötter; Barbara E Golden; Peter Richmond; Nigel Klein; Ilya Z Kovar; John H Beattie; Beata Wolska-Kusnierz; Yoshiaki Saito; Johannes Roth
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

4.  Inhibitory influence of protease-activated receptor 2 and E-prostanoid receptor stimulants in lipopolysaccharide models of acute airway inflammation.

Authors:  Terence Peters; Tracy S Mann; Peter J Henry
Journal:  J Pharmacol Exp Ther       Date:  2010-08-05       Impact factor: 4.030

5.  Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice.

Authors:  James D Moffatt; Kate L Jeffrey; Thomas M Cocks
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

6.  Delayed onset of inflammation in protease-activated receptor-2-deficient mice.

Authors:  J R Lindner; M L Kahn; S R Coughlin; G R Sambrano; E Schauble; D Bernstein; D Foy; A Hafezi-Moghadam; K Ley
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

7.  Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane.

Authors:  P Youssef; J Roth; M Frosch; P Costello; O Fitzgerald; C Sorg; B Bresnihan
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

Review 8.  Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.

Authors:  Karol A Kaminski; Tomasz A Bonda; Janusz Korecki; Wlodzimierz J Musial
Journal:  Int J Cardiol       Date:  2002-11       Impact factor: 4.164

9.  The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils.

Authors:  Jacques Doussiere; Farid Bouzidi; Pierre V Vignais
Journal:  Eur J Biochem       Date:  2002-07

10.  Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice.

Authors:  Rosana L Pagano; Maria Angela Amorim Dias; Camila S Dale; Renata Giorgi
Journal:  Mediators Inflamm       Date:  2002-08       Impact factor: 4.711

View more
  14 in total

1.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

Review 2.  Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development.

Authors:  Katie O'Callaghan; Athan Kuliopulos; Lidija Covic
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

3.  Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma.

Authors:  S Tabur; H Korkmaz; M Özkaya; U Elboğa; M Tarakçıoglu; N Aksoy; E Akarsu
Journal:  Tumour Biol       Date:  2015-04-29

4.  Short-Term Effects of Sepsis and the Impact of Aging on the Transcriptional Profile of Different Brain Regions.

Authors:  Mike Yoshio Hamasaki; Patricia Severino; Renato David Puga; Marcia Kiyomi Koike; Camila Hernandes; Hermes Vieira Barbeiro; Denise Frediani Barbeiro; Marcel Cerqueira César Machado; Eduardo Moraes Reis; Fabiano Pinheiro da Silva
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

5.  The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice.

Authors:  Ying Sun; Yu Lu; Christopher G Engeland; Sara C Gordon; Herve Y Sroussi
Journal:  Mol Immunol       Date:  2012-11-03       Impact factor: 4.407

6.  Neuroprotective effect of protease-activated receptor-2 in the hypoxia-induced apoptosis of rat RGC-5 cells.

Authors:  Yanli Peng; Jiaping Zhang; Haiwei Xu; Jianrong He; Xi Ying; Yi Wang
Journal:  J Mol Neurosci       Date:  2012-09-05       Impact factor: 3.444

7.  Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.

Authors:  Julie Quoyer; Jay M Janz; Jiansong Luo; Yong Ren; Sylvain Armando; Viktoria Lukashova; Jeffrey L Benovic; Kenneth E Carlson; Stephen W Hunt; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-05       Impact factor: 11.205

Review 8.  S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.

Authors:  Alexandru Schiopu; Ovidiu S Cotoi
Journal:  Mediators Inflamm       Date:  2013-12-22       Impact factor: 4.711

9.  Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes.

Authors:  Eun Ok Lee; Ji Hye Yang; Keun-A Chang; Yoo-Hun Suh; Young Hae Chong
Journal:  J Neuroinflammation       Date:  2013-05-30       Impact factor: 8.322

10.  A Novel Pkhd1 Mutation Interacts with the Nonobese Diabetic Genetic Background To Cause Autoimmune Cholangitis.

Authors:  Wenting Huang; Daniel B Rainbow; Yuehong Wu; David Adams; Pranavkumar Shivakumar; Leah Kottyan; Rebekah Karns; Bruce Aronow; Jorge Bezerra; M Eric Gershwin; Laurence B Peterson; Linda S Wicker; William M Ridgway
Journal:  J Immunol       Date:  2017-11-20       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.